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http://dx.doi.org/10.1016/j.jmii.2012The number of cases of community-associated methicillin-resistant Staphylococcus aureus
(CA-MRSA) pneumonia has increased since the late 1990s, with skin and soft tissue infections
predominant among neonates. Herein, we present a rare case of CA-MRSA necrotizing
pneumonia with empyema following respiratory syncytial virus (RSV) infection in a healthy
neonate. Despite prompt vancomycin treatment, the disease worsened and finally we had to
perform pneumonectomy. This case highlights the possibility of emerging CA-MRSA-related
invasive disease among neonates.
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.07.001Introduction
The number of cases of community-associated methicillin-
resistant Staphylococcus aureus (CA-MRSA) infection has
increased worldwide over the last decade.1 In neonates,
a majority of CA-MRSA infections involve skin and soft
tissues. Although not often seen, the invasive disease does
occur even in previously healthy term or near-term infants.
This is an emerging disease that might cause seriousished by Elsevier Taiwan LLC. All rights reserved.
556 W.H. Lim et al.hazards to the health of newborn infants universally. We
present a rare case of CA-MRSA necrotizing pneumonia
following respiratory syncytial virus (RSV) upper respiratory
tract illness in a healthy term neonate. The severity of her
course may be attributed to the PantoneValentine leuko-
cidin (PVL) carrying sequence type 59 (ST59) strain.Figure 2. The first chest computed tomography scan of the
patient showing necrotizing pneumonia of the right lung with
bronchopleural fistula (abnormal air collection; large arrow)
and empyema formation (low-density fluid collection with
fibrin content; small arrow).Case report
A 23-day-old female infant presented to the emergency
room (ER) with fever, cough, progressive dyspnea, and
lethargy. She was born at 38 weeks’ gestation to a 29-year-
old woman after uncomplicated pregnancy, and the peri-
natal course was uneventful. She was discharged home on
the 3rd day of life and breastfed with good body weight
gain. While the mother and sibling had symptoms of
common cold, this infant began to develop cough, rhinor-
rhea, and fever on the 13th day of life. Her symptoms waxed
and waned for a while but she was eventually brought to
the ER due to high fever and progressive dyspnea on the
23rd day of life. Her chest X-ray (CXR) showed right lobar
pneumonia and pneumatocele formation (Fig. 1). She also
had leukocytosis with left shift: white blood cell count
30.8  109/L; with 16% band form; 46% segment; and 18%
lymphocyte. C-reactive protein level was 262.5 mg/dL.
She was admitted to the neonatal intensive care unit
with oxygen and positive pressure support via nasal prongs.
Oxacillin (75-mg intravenous injection every 6 hours) and
cefotaxime (150-mg intravenous injection every 8 hours)
were empirically administered. However, her respiratory
condition rapidly deteriorated while CXR revealed pneu-
mothorax and worsening pneumatocele formation over the
right lung. Chest computed tomography scan confirmed
necrotizing pneumonia of the right lung with broncho-
pleural fistula and empyema formation (Fig. 2). Endotra-
cheal intubation and chest tube insertion were performed.
Her endotracheal aspirate, pleural effusion, and blood
culture all grew methicillin-resistant S. aureus (MRSA) that
was sensitive to vancomycin. The result of sputum enzyme-
linked immunosorbent assay for RSV antigen was positive.
Despite starting vancomycin treatment (45-mg intravenousFigure 1. Chest film upon admission showing right lobar
pneumonia and pneumatocele formation (white arrowhead).injection every 8 hours) on the 2nd day of admission, her
clinical condition continued to deteriorate. She finally
underwent partial pneumonectomy of the right upper and
lower lobes on admission day 7. Culture of intraoperative
pleural fluid still grew MRSA. Her condition improved and
the patient came off mechanical ventilation 3 days after
the operation. However, even though vancomycin had been
given without interruption, she developed fever 3 days
later and was reintubated. Her respiratory condition dete-
riorated to the point that high-frequency oscillatory
ventilation with 100% fraction of inspired oxygen could only
barely maintain her oxygen levels. Extracorporeal
membrane oxygenation was proposed but it was declined
by her parents. Because of treatment failure, the patient’s
antibiotic was switched to linezolid (30-mg intravenous
injection every 8 hours) after 18 days of vancomycin
therapy.
She developed necrotizing pneumonia again in the
remaining right lower lung with bronchopleural fistula and
pneumothorax. A second total right lung pneumonectomy
was performed on the 40th day of admission. Microscopic
examination of the removed tissue showed diffuse atelec-
tasis, fibrosis, bronchitis, and abscess formation. She
received linezolid for a period of 3 weeks without inad-
vertent effects, and the patient eventually came off
ventilator support 2 weeks after the second surgery.
This infant was oxygen-dependent until she was 3
months old with normal development at 1 year of age. Her
immunological studies including immunoglobulin levels and
cluster of differentiation subsets were all normal.
Five MRSA isolates, including two isolates from blood-
stream, one isolate each from pleural effusion, sputum, and
pus specimen, were collected for microbiological charac-
terization. All the five isolates had the same antibiogram,
showing resistance to clindamycin and erythromycin, and
susceptibility to trimethoprim/sulfamethoxazole, vanco-
mycin, teicoplanin, tigecycline, and linezolid. All the five
isolates also shared common molecular characteristics and
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(PFGE) type D4 (similar to USA1000), ST59 by multilocus
sequence typing, carrying staphylococcal cassette chromo-
some mec (SCCmec)-typeVT genes, and possessing PVL
genes, which are typical molecular characteristics of CA-
MRSA in Taiwan.2
Discussion
As CA-MRSA becomes more prevalent, it is inevitable that
we will encounter CA-MRSA-related invasive disease more
often. As our case may imply, CA-MRSA could play an
increasingly important role in neonatal pneumonia. As the
first case of CA-MRSA pneumonia among neonates in
Taiwan, the clinical presentation of neonatal CA-MRSA
pneumonia is similar to that in older children with charac-
teristics of respiratory failure, high fever, abnormal CXR
from empyema to necrotizing pneumonia.2
The CA-MRSA clones are different in different regions of
the world. For example, USA300 strain multilocus sequence
type (MLST8) prevails in the United States, Canada, and in
some European countries, whereas strains of ST30 clonal
linage are common in Australia, Japan, and Greece, while
strains of ST80 clonal linage are common in Europe.3e5 In
Taiwan, most of the CA-MRSA clinical isolates have been
characterized as ST59/PFGE type D/SCCmec VT/PVL-posi-
tive, and so are the isolates from our presented case.2,6 A
majority of CA-MRSA isolates possess PVL genes. PVL genes,
which cause leukocyte destruction and tissue necrosis, are
reported to be associated with skin infections and necro-
tizing pneumonia in both clinical cases and murine
models.7e10
A preceding viral infection has been proposed as the
initiating event in severe necrotizing pneumonia, and may
contribute to the severity of CA-MRSA infection. Hageman
et al reported that patients with invasive CA-MRSA pneu-
monia were frequently preceded by an influenza-like
illness.11 After the viral infection, the respiratory epithe-
lium is injured and this enhanced the binding of PVL-posi-
tive S. aureus strains.8 The preceding upper respiratory
tract infection 10 days before admission and the co-
infection of RSV can be attributed to the severity of CA-
MRSA pneumonia in our patient.
Treatment of CA-MRSA infections should be stratified
according to the site and severity of disease as well as
national epidemiology and antibiotic susceptibility
pattern.6 Although CA-MRSA strains generally retain
susceptibility to trimethoprim/sulfamethoxazole, flour-
oquinolones, gentamicin, their resistance to clindamycin
and macrolides is increasing.12 In Taiwan, up to 94e97% of
the CA-MRSAs are resistant to clindamycin and erythro-
mycin.2 Concerning fatality of invasive CA-MRSA infection
due to delayed use of effective antibiotics, glycopeptides
such as vancomycin are advised to be used empirically and
continued until susceptibility test is available for invasive
disease.2,6 However, if there is no satisfactory response to
vancomycin therapy, linezolid, a member of oxazolidinonesthat inhibits bacterial protein synthesis, can be considered
as an alternative in treating invasive CA-MRSA infection, as
in the current case.13
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